Sarah Jefferies
Papers
2
Total Citations
84
H-Index
2
About
Sarah Jefferies is a leading clinical researcher in head and neck oncology, with a focused expertise in the surgical management of oropharyngeal carcinoma, particularly in the context of human papillomavirus (HPV)-associated disease. Her major contribution lies in rigorously comparing the efficacy of minimally invasive surgical techniques—such as transoral robotic surgery and transoral laser microsurgery—against traditional radiotherapy and chemoradiotherapy for early-stage and small-volume oropharyngeal cancers. Her landmark 2016 study, which has garnered 82 citations, provides critical evidence on outcomes for patients with HPV-positive tumors, a growing demographic that presents at younger ages and higher stages. This work directly addresses the global rise in oropharyngeal squamous cell carcinoma incidence, offering data to guide treatment de-escalation and improve quality of life. Additionally, her 2014 Cochrane protocol established a foundational framework for systematic review in this area. Jefferies’ research is pivotal for clinicians navigating the balance between oncologic control and functional preservation, and her findings continue to shape international treatment guidelines for early-stage oropharyngeal carcinoma.
Research Focus
Key Achievements
Top Papers
- 1
- 2